Riskpilot← Back to searchSign inGet full accessBIOGLAN AS
ASActiveOrg 970968660Lilleakerveien 8, 0283 OsloWholesale of perfume and cosmetics · NACE 4645Est. 19940 employees
Revenue 2024
NOK 0
EBITDA margin
—
-141% vs 2023
Equity ratio
76.2%
Financial strength
Net profit 2024
NOK 5K
-100% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -98K | -141% |
| Net profit | NOK 5K | -100% |
| Total assets | NOK 546M | -5% |
| Equity | NOK 415,9M | +0% |
| Employees | 0 | — |
Legal name
BIOGLAN AS
Org number
970968660
Legal form
Aksjeselskap
NACE code
4645 · Wholesale of perfume and cosmetics
Founded
22. april 1994
Share capital
NOK 1 540 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg. Styrets leder alene. Daglig leder alene.
Company purpose
Handel og import av skjønnhets- og velværeprodukter, samt hva som står i denne forbindelse, eller å ha eierinteresser i selskaper med slik virksomhet.
Address
Lilleakerveien 8, 0283 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 3 000 | 4 022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −1 584 | 2 936 | 4 012 | −1 | −38 | −69 | −69 | −40 | −65 | −39 | −41 | −98 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −1 584 | 2 936 | 4 012 | −1 | −38 | −69 | −69 | −40 | −65 | −39 | −41 | −98 |
| Net financials | −5 711 | 55 705 | −4 045 | 115 961 | 22 381 | 21 438 | 70 612 | 56 | 77 | 49 | 50 048 | 104 |
| Profit before tax | −7 295 | 58 641 | −33 | 115 959 | 22 343 | 21 369 | 70 543 | 15 | 12 | 10 | 50 008 | 6 |
| Tax | −12 536 | −0 | 33 | −217 | 5 682 | 5 021 | 2 319 | 3 | 3 | 2 | 2 | 1 |
| Net profit | 5 241 | 59 818 | −66 | 116 176 | 16 661 | 16 348 | 68 223 | 12 | 9 | 8 | 50 006 | 5 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 268 298 | 375 243 | 306 093 | 557 156 | 605 736 | 580 414 | 564 124 | 520 940 | 521 729 | 522 527 | 573 112 | 546 029 |
| Equity | 128 756 | 188 574 | 188 508 | 304 684 | 341 345 | 447 693 | 405 917 | 365 928 | 365 931 | 365 938 | 415 944 | 415 949 |
| Long-term debt | 93 820 | 172 402 | 117 510 | 250 312 | 262 879 | 130 067 | 153 823 | 153 823 | 153 823 | 153 823 | 153 823 | 130 067 |
| Short-term debt | 45 721 | 14 267 | 75 | 2 159 | 1 512 | 2 653 | 4 384 | 1 188 | 1 975 | 2 765 | 3 344 | 12 |
| Total debt | 139 541 | 186 669 | 117 585 | 252 472 | 264 391 | 132 721 | 158 207 | 155 011 | 155 798 | 156 588 | 157 168 | 130 080 |
EBITDA margin
-9799200.0%
This company
15.8%
Market median
-62020353% vs market
20132024
Equity ratio
76.2%
This company
38.2%
Market median
+99% vs market
20132024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20132024
Net profit margin
485400.0%
This company
8.1%
Market median
+5992493% vs market
20132024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20132024
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20132024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2025 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Midelfart Sonesson Ab | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BIOGLAN AS 
MIDSONA NORGE ASBoard members of BIOGLAN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Johan Henrik Hjalmarsson | Chairman | 0 companies |
| Tora Maria Molander | Board of Directors | 0 companies |
| Peter Sven-Eric Åsberg | Chairman | 0 companies |